DAVID GLENN: Open Payments
NPI 1316491673 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,419 in 67 payments from 9 companies in 2025. Trend: 2023 $633 · 2024 $1,425 · 2025 $2,419
Food & beverage: $2,419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $597 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $517 |
| Axsome Therapeutics, Inc. | 7 | $391 |
| Vanda Pharmaceuticals Inc. | 7 | $330 |
| E.R. Squibb & Sons, L.L.C. | 4 | $245 |
| Teva Pharmaceuticals USA, Inc. | 4 | $169 |
| Janssen Pharmaceuticals, Inc | 1 | $106 |
| Alkermes, Inc. | 2 | $49 |
| Almatica Pharma LLC | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Auvelity, FANAPT, COBENFY, UZEDY, SPRAVATO, HETLIOZ.
Industry payments across OH — which companies pay providers there.
